Literature DB >> 20709158

Noradrenaline release in the locus coeruleus modulates memory formation and consolidation; roles for α- and β-adrenergic receptors.

M E Gibbs1, D S Hutchinson, R J Summers.   

Abstract

Noradrenaline, essential for the modulation of memory, is released in various parts of the brain from nerve terminals controlled by the locus coeruleus (LoC). Noradrenaline release consequent upon input from higher brain areas also occurs within the LoC itself. We examined the effect of noradrenaline on adrenergic receptors in the LoC on memory processing, using colored bead discrimination learning in the young domestic chick. We have shown previously that the release of noradrenaline in the hippocampus and cortex (mesopallium) is essential for acquisition and consolidation of short-term to intermediate and to long-term memory. Noradrenaline release within the LoC is triggered by the glutamatergic input from the forebrain. Inhibition by LoC injection of NMDA or AMPA receptor antagonists is rescued by injection of β2-and β3-adrenoceptor (AR) agonists in the hippocampus. We show that inhibition of α2A-ARs by BRL44408 in the LoC up to 30 min post-training consolidates weakly-reinforced learning. Conversely activation of α2A-ARs in the LoC at the times of consolidation between short-term and intermediate and long-term memory caused memory loss, which is likely to be due to a decreased release of noradrenaline within these two time windows. The α2A-AR antagonist will block presynaptic inhibitory receptors leading to an increase in extracellular noradrenaline. This interpretation is supported by the actions of noradrenaline uptake blockers that produce the same memory outcome. BRL44408 in the mesopallium also caused memory enhancement. β2-ARs are important in the first time window, whereas α1-, α2C-and β3-ARs are important in the second time window. The results reveal that for successful memory formation noradrenaline release is necessary within the LoC as well as in other brain regions, at the time of consolidation of memory from short-term to intermediate and from intermediate to long-term memory.
Copyright © 2010 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20709158     DOI: 10.1016/j.neuroscience.2010.07.052

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  32 in total

1.  Rapid turnover of glycogen in memory formation.

Authors:  Marie E Gibbs; Dana S Hutchinson
Journal:  Neurochem Res       Date:  2012-06-05       Impact factor: 3.996

2.  Comparison of the VTA and LC response to methylphenidate: a concomitant behavioral and neuronal study of adolescent male rats.

Authors:  Tahseen J Karim; Cruz Reyes-Vazquez; Nachum Dafny
Journal:  J Neurophysiol       Date:  2017-06-14       Impact factor: 2.714

3.  Locus Coeruleus Degeneration Induces Forebrain Vascular Pathology in a Transgenic Rat Model of Alzheimer's Disease.

Authors:  Sarah C Kelly; Erin C McKay; John S Beck; Timothy J Collier; Anne M Dorrance; Scott E Counts
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

Review 4.  Reflections on glycogen and β-amyloid: why does glycogenolytic β2-adrenoceptor stimulation not rescue memory after β-amyloid?

Authors:  Marie Gibbs
Journal:  Metab Brain Dis       Date:  2014-05-09       Impact factor: 3.584

5.  A heuristic model for working memory deficit in schizophrenia.

Authors:  Zhen Qi; Gina P Yu; Felix Tretter; Oliver Pogarell; Anthony A Grace; Eberhard O Voit
Journal:  Biochim Biophys Acta       Date:  2016-05-10

Review 6.  Norepinephrine: a neuromodulator that boosts the function of multiple cell types to optimize CNS performance.

Authors:  John O'Donnell; Douglas Zeppenfeld; Evan McConnell; Salvador Pena; Maiken Nedergaard
Journal:  Neurochem Res       Date:  2012-06-21       Impact factor: 3.996

7.  Propranolol inhibition of β-adrenergic receptor does not suppress pathologic neovascularization in oxygen-induced retinopathy.

Authors:  Jing Chen; Jean-Sebastian Joyal; Colman J Hatton; Aimee M Juan; Dorothy T Pei; Christian G Hurst; Dan Xu; Andreas Stahl; Ann Hellstrom; Lois E H Smith
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-05-17       Impact factor: 4.799

8.  Astroglial Vesicular Trafficking in Neurodegenerative Diseases.

Authors:  Robert Zorec; Vladimir Parpura; Alexei Verkhratsky
Journal:  Neurochem Res       Date:  2016-09-14       Impact factor: 3.996

9.  Administration of a selective β2 adrenergic receptor antagonist exacerbates neuropathology and cognitive deficits in a mouse model of Alzheimer's disease.

Authors:  Caterina Branca; Elena V Wisely; Lauren K Hartman; Antonella Caccamo; Salvatore Oddo
Journal:  Neurobiol Aging       Date:  2014-06-16       Impact factor: 4.673

Review 10.  Astrocyte glycogen and lactate: New insights into learning and memory mechanisms.

Authors:  Cristina M Alberini; Emmanuel Cruz; Giannina Descalzi; Benjamin Bessières; Virginia Gao
Journal:  Glia       Date:  2017-10-27       Impact factor: 7.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.